$VBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Vitality Biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Vitality Biopharma, Inc.. Get notifications about new insider transactions in Vitality Biopharma, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 09 2021 | VBIO | Vitality Biopharma ... | Zipp Brandon Joel | Chief Science Offic ... | Buy | P | 0.19 | 19,071 | 3,623 | 64,000 | 44.9 K to 64 K (+42.45 %) |
Feb 09 2021 | VBIO | Vitality Biopharma ... | Zipp Brandon Joel | Chief Science Offic ... | Buy | P | 0.17 | 30,929 | 5,258 | 44,929 | 14 K to 44.9 K (+220.92 %) |
Jul 01 2019 | VBIO | Vitality Biopharma ... | MCKILLIGAN RICHARD | Chief Financial Off ... | Option Exercise | A | 0.30 | 250,000 | 75,000 | 745,234 | |
Jul 01 2019 | VBIO | Vitality Biopharma ... | Cavanaugh Michael R. | Chief Executive Off ... | Option Exercise | A | 0.30 | 250,000 | 75,000 | 750,000 | |
May 20 2019 | VBIO | Vitality Biopharma ... | Celeste Richard F | Director | Option Exercise | A | 0.35 | 500,000 | 175,000 | 500,000 | |
May 13 2019 | VBIO | Vitality Biopharma ... | MAIDA ANTHONY E III | Director | Option Exercise | A | 0.35 | 500,000 | 175,000 | 612,559 | |
May 13 2019 | VBIO | Vitality Biopharma ... | Cavanaugh Michael R. | CEO | Option Exercise | A | 0.35 | 500,000 | 175,000 | 500,000 | |
May 13 2019 | VBIO | Vitality Biopharma ... | FEIGHAN EDWARD F | Director | Option Exercise | A | 0.35 | 500,000 | 175,000 | 500,000 | |
Apr 02 2019 | VBIO | Vitality Biopharma ... | LoConti Joseph E. | 10% Owner | Buy | P | 0.46 | 4,447,651 | 2,045,919 | 4,477,651 | 30 K to 4.5 M (+14,825.50 %) |
Feb 07 2019 | VBIO | Vitality Biopharma ... | LoConti Joseph E. | 10% Owner | Option Exercise | J | 3.00 | 1,556,666 | 4,669,998 | 0 | |
Feb 07 2019 | VBIO | Vitality Biopharma ... | LoConti Joseph E. | 10% Owner | Option Exercise | J | 3.00 | 325,000 | 975,000 | 0 | |
Feb 07 2019 | VBIO | Vitality Biopharma ... | LoConti Joseph E. | 10% Owner | Option Exercise | J | 2.00 | 166,667 | 333,334 | 0 | |
Feb 07 2019 | VBIO | Vitality Biopharma ... | LoConti Joseph E. | 10% Owner | Buy | J | 0.00 | 3,540,763 | 0 | 6,130,479 | 2.6 M to 6.1 M (+136.72 %) |
Feb 07 2019 | VBIO | Vitality Biopharma ... | LoConti Joseph E. | 10% Owner | Buy | J | 0.00 | 907,292 | 0 | 1,281,042 | 373.8 K to 1.3 M (+242.75 %) |
Feb 07 2019 | VBIO | Vitality Biopharma ... | LoConti Joseph E. | 10% Owner | Buy | J | 0.00 | 930,557 | 0 | 1,263,891 | 333.3 K to 1.3 M (+279.17 %) |
Jan 29 2019 | VBIO | Vitality Biopharma ... | Cavanaugh Michael R. | Director | Option Exercise | J | 3.00 | 50,000 | 150,000 | 0 | |
Jan 29 2019 | VBIO | Vitality Biopharma ... | Cavanaugh Michael R. | Director | Buy | J | 0.00 | 572,291 | 0 | 879,791 | 307.5 K to 879.8 K (+186.11 %) |
Jan 29 2019 | VBIO | Vitality Biopharma ... | FEIGHAN EDWARD F | Director | Option Exercise | J | 3.00 | 167,500 | 502,500 | 0 | |
Jan 29 2019 | VBIO | Vitality Biopharma ... | FEIGHAN EDWARD F | Director | Option Exercise | J | 3.00 | 502,500 | 1,507,500 | 0 | |
Jan 29 2019 | VBIO | Vitality Biopharma ... | FEIGHAN EDWARD F | Director | Buy | J | 0.00 | 467,604 | 0 | 685,228 | 217.6 K to 685.2 K (+214.87 %) |
Jan 29 2019 | VBIO | Vitality Biopharma ... | FEIGHAN EDWARD F | Director | Buy | J | 0.00 | 1,402,813 | 0 | 2,005,689 | 602.9 K to 2 M (+232.69 %) |
Aug 18 2016 | STVF | Vitality Biopharma ... | MAIDA ANTHONY E III | Director | Option Exercise | A | 0.50 | 92,559 | 46,280 | 112,559 | |
Aug 18 2016 | STVF | Vitality Biopharma ... | MAIDA ANTHONY E III | Director | Option Exercise | A | 2.10 | 10,000 | 21,000 | 20,000 | |
Aug 18 2016 | STVF | Vitality Biopharma ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
Aug 17 2016 | STVF | Vitality Biopharma ... | Brooke Robert T. | Chief Executive Off ... | Option Exercise | A | 0.00 | 510,585 | 0 | 965,585 | |
Aug 17 2016 | STVF | Vitality Biopharma ... | Brooke Robert T. | Chief Executive Off ... | Option Exercise | A | 0.50 | 415,000 | 207,500 | 455,000 | |
Aug 17 2016 | STVF | Vitality Biopharma ... | Brooke Robert T. | Chief Executive Off ... | Option Exercise | A | 2.10 | 40,000 | 84,000 | 40,000 | |
Aug 17 2016 | STVF | Vitality Biopharma ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.00 | 925,585 | 0 | 1,015,585 | |
Aug 17 2016 | STVF | Vitality Biopharma ... | DHILLON AVTAR S | Director | Option Exercise | A | 2.10 | 40,000 | 84,000 | 90,000 | |
Mar 21 2012 | STVF | Stevia First Corp. | Brooke Robert T. | CEO, SECRETARY, TRE ... | Buy | P | 0.00 | 2,572,500 | 5,660 | 2,572,500 | 0 to 2.6 M |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Option Exercise | A | 0.10 | 500,000 | 50,000 | 500,000 | |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,000,000 | 4,400 | 5,150,000 | 7.2 M to 5.2 M (-27.97 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,227,500 | 4,901 | 7,150,000 | 9.4 M to 7.2 M (-23.75 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 1,000,000 | 2,200 | 9,377,500 | 10.4 M to 9.4 M (-9.64 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 400,000 | 880 | 10,377,500 | 10.8 M to 10.4 M (-3.71 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,400,000 | 5,280 | 10,777,500 | 13.2 M to 10.8 M (-18.21 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,300,000 | 5,060 | 13,177,500 | 15.5 M to 13.2 M (-14.86 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,400,000 | 5,280 | 15,477,500 | 17.9 M to 15.5 M (-13.42 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,050,000 | 4,510 | 17,877,500 | 19.9 M to 17.9 M (-10.29 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,100,000 | 4,620 | 19,927,500 | 22 M to 19.9 M (-9.53 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,250,000 | 4,950 | 22,027,500 | 24.3 M to 22 M (-9.27 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,450,000 | 5,390 | 24,277,500 | 26.7 M to 24.3 M (-9.17 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,200,000 | 4,840 | 26,727,500 | 28.9 M to 26.7 M (-7.61 %) |
Mar 21 2012 | STVF | Stevia First Corp. | DHILLON AVTAR S | Director | Sell | S | 0.00 | 2,572,500 | 5,660 | 28,927,500 | 31.5 M to 28.9 M (-8.17 %) |
Aug 17 2011 | STVF | Stevia First Corp. | Chen Tao | Sell | S | 67,500.00 | 4,500,000 | 303,750,000,000 | 0 | 4.5 M to 0 (-100.00 %) |
Page: 1